Abstract
Breast cancer (BC) is the most commonly diagnosed cancer in women and the second leading cause of cancer death in Greece. The economic burden of BC is substantial and has been steadily increasing. The aim of this study was to provide the first estimate on the direct costs associated with the management of metastatic BC (mBC) in Greece.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
